巴里西提尼布组合疗法在快速进展性系统性硬化症中显著改善了心脏导电缺陷:一个病例报告
Xiaoyan Su1, Huixia Wu1, Hairui Li2
1Department of Rheumatology and Immunology, the First Affiliated Hospital, Jinan University, Guangzhou, 510632, People's Republic of China.
Open access rheumatology : research and reviews
|September 8, 2025
概括
巴里西丁尼布 (JAK抑制剂) 在治疗严重系统性硬化症 (SSc) 与心脏和肺部并发症方面表现有前途. 这种组合疗法改善了耐火患者的心脏功能,肺部疾病和皮肤硬化.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
背景情况:
- 系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病,其特征是纤维化影响多个器官.
- 具有严重心脏和肺部干扰的耐火性SSc带来了重大管理挑战和不良预后.
- 传统的治疗方法在晚期的SSc病例中通常具有有限的疗效.
研究的目的:
- 评估巴里西替尼与耐火性,快速进展性全身性硬化症 (SSc) 患者的其他疗法联合治疗的有效性.
- 评估巴里西提尼布对SSc严重心脏导电缺陷和间歇性肺病 (ILD) 的影响.
主要方法:
- 一个48岁的男性患者的案例研究,他患有先进的SSc,心脏扩大,心房静脉阻塞,心力衰竭,ILD和肠道阻塞.
- 患者在之前的治疗 (MMF,tacrolimus,CTX) 失败后接受了一种组合治疗方案,包括葡萄糖皮质激素,IVIg,环胺 (CTX) 和巴里西提尼布 (每天4毫克).
主要成果:
- 观察到显著的临床改善,包括心脏大小减少,鼻节律恢复,心力衰竭消失.
- 间歇性肺病 (ILD) 和皮肤硬化症的实质性回归,在肺功能测试中显著恢复.
- 胃肠道症状的完全消失,如腹痛和膨胀.
结论:
- 作为辅助疗法,巴里西替尼 (baricitinib) 显示出在治疗具有多器官参与的耐火性SSc方面的潜力.
- 观察到的改善表明Janus激酶 (JAK) 抑制剂可能是严重的,耐治疗的SSc.的有前途的治疗选择.
- 这个案例支持进一步调查JAK抑制剂的SSc患者心脏和肺部表现.
更多相关视频
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.9K
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
2.1K
相关概念视频
01:21Rheumatic Heart Disease III: Medical Management
290
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
290
01:14Myocarditis III: Medical Management
178
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
178
01:17Pericarditis III: Medical Management
316
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
316
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
501
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
501
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
472
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
472
01:20Rheumatic Heart Disease IV: Nursing Management
276
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
276